WO2007012019A3 - Medicaments containing famotidine and ibuprofen and administration of same - Google Patents
Medicaments containing famotidine and ibuprofen and administration of same Download PDFInfo
- Publication number
- WO2007012019A3 WO2007012019A3 PCT/US2006/028075 US2006028075W WO2007012019A3 WO 2007012019 A3 WO2007012019 A3 WO 2007012019A3 US 2006028075 W US2006028075 W US 2006028075W WO 2007012019 A3 WO2007012019 A3 WO 2007012019A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- ibuprofen
- administration
- same
- medicaments containing
- containing famotidine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pain & Pain Management (AREA)
- Toxicology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2006800324428A CN101257800B (en) | 2005-07-18 | 2006-07-18 | Medicaments containing famotidine and ibuprofen |
NZ565846A NZ565846A (en) | 2005-07-18 | 2006-07-18 | Medicaments containing famotidine and ibuprofen and administration of same |
EP06800140A EP1919288A4 (en) | 2005-07-18 | 2006-07-18 | Medicaments containing famotidine and ibuprofen and administration of same |
JP2008522937A JP2009501801A (en) | 2005-07-18 | 2006-07-18 | Medicament containing ibuprofen and famotidine and its administration |
CA2615496A CA2615496C (en) | 2005-07-18 | 2006-07-18 | Medicaments containing famotidine and ibuprofen and administration of same |
AU2006269894A AU2006269894B2 (en) | 2005-07-18 | 2006-07-18 | Medicaments containing famotidine and ibuprofen and administration of same |
IL188732A IL188732A (en) | 2005-07-18 | 2008-01-13 | Use of ibuprofen and famotidine in the preparation of medicaments |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US70048105P | 2005-07-18 | 2005-07-18 | |
US60/700,481 | 2005-07-18 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2007012019A2 WO2007012019A2 (en) | 2007-01-25 |
WO2007012019A3 true WO2007012019A3 (en) | 2007-11-01 |
Family
ID=37669550
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2006/028078 WO2007012022A2 (en) | 2005-07-18 | 2006-07-18 | Unit dose form with ibuprofen-famotidine admixture |
PCT/US2006/028075 WO2007012019A2 (en) | 2005-07-18 | 2006-07-18 | Medicaments containing famotidine and ibuprofen and administration of same |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2006/028078 WO2007012022A2 (en) | 2005-07-18 | 2006-07-18 | Unit dose form with ibuprofen-famotidine admixture |
Country Status (8)
Country | Link |
---|---|
US (3) | US20070043097A1 (en) |
EP (1) | EP1919288A4 (en) |
JP (1) | JP2009501801A (en) |
CN (1) | CN101257800B (en) |
CA (1) | CA2615496C (en) |
IL (1) | IL188732A (en) |
NZ (1) | NZ565846A (en) |
WO (2) | WO2007012022A2 (en) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3516632B2 (en) | 2000-04-27 | 2004-04-05 | オリジン電気株式会社 | Method and apparatus for bonding optical disk substrates |
US8067451B2 (en) | 2006-07-18 | 2011-11-29 | Horizon Pharma Usa, Inc. | Methods and medicaments for administration of ibuprofen |
US20080020040A1 (en) * | 2006-07-18 | 2008-01-24 | Horizon Therapeutics, Inc. | Unit dose form for administration of ibuprofen |
US20080021078A1 (en) * | 2006-07-18 | 2008-01-24 | Horizon Therapeutics, Inc. | Methods and medicaments for administration of ibuprofen |
PL2043637T3 (en) | 2006-07-18 | 2012-06-29 | Horizon Pharma Usa Inc | Methods and medicaments for administration of ibuprofen |
US8067033B2 (en) * | 2007-11-30 | 2011-11-29 | Horizon Pharma Usa, Inc. | Stable compositions of famotidine and ibuprofen |
US20150224056A1 (en) * | 2006-07-18 | 2015-08-13 | Horizon Pharma Usa, Inc. | Pharmaceutical compositions of ibuprofen and famotidine |
US20100297224A1 (en) * | 2006-08-31 | 2010-11-25 | Horizon Therapeutics, Inc. | NSAID Dose Unit Formulations with H2-Receptor Antagonists and Methods of Use |
WO2008091957A2 (en) * | 2007-01-24 | 2008-07-31 | Horizon Therapeutics, Inc. | Pharmaceutical compositions containing famotidine and ibuprofen and having improved content uniformity |
WO2009089134A1 (en) * | 2008-01-04 | 2009-07-16 | Src, Inc. | Methods for measuring a patint response upon administration of a drug and compositions thereof |
EP2309988B1 (en) | 2008-07-21 | 2015-11-25 | SI Group, Inc. | High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms |
US9629809B2 (en) | 2008-07-21 | 2017-04-25 | Si Group, Inc. | High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms |
CN102985077A (en) * | 2010-07-02 | 2013-03-20 | Fmc有限公司 | Solid forms |
WO2013054352A1 (en) | 2011-08-17 | 2013-04-18 | Cadila Healthcare Limited | Pharmaceutical compositions of ibuprofen and famotidine |
CN102247371A (en) * | 2011-08-19 | 2011-11-23 | 北京阜康仁生物制药科技有限公司 | Medicament compound by taking ibuprofen and Lafutidine as active ingredients |
CN103083314A (en) * | 2011-10-28 | 2013-05-08 | 四川大学 | Compound ibuprofen having gastrointestinal protective effect |
WO2015163832A1 (en) | 2014-04-25 | 2015-10-29 | Pharmacti̇ve İlaç Sanayi̇ Ve Ti̇caret A.Ş. | An ibuprofen and famotidine combined composition having improved stability |
EP3368029A1 (en) * | 2015-10-30 | 2018-09-05 | Cancer Prevention Pharmaceuticals, Inc. | Eflornithine and sulindac, fixed dose combination formulation |
BR112019016935A2 (en) | 2017-02-17 | 2020-04-07 | Eidos Therapeutics Inc | processes for preparing ag-10, its intermediates and salts thereof |
AU2019321583A1 (en) | 2018-08-17 | 2021-01-21 | Eidos Therapeutics, Inc. | Formulations of AG10 |
CA3124579A1 (en) | 2020-07-15 | 2022-01-15 | Schabar Research Associates Llc | Unit oral dose compositions composed of naproxen sodium and famotidine for the treatment of acute pain and the reduction of the severity of heartburn and/or the risk of heartburn |
AU2021310264A1 (en) | 2020-07-15 | 2023-02-09 | Schabar Research Associates Llc | Unit oral dose compositions composed of ibuprofen and famotidine for the treatment of acute pain and the reduction of the severity and/or risk of heartburn |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5496836A (en) * | 1994-05-05 | 1996-03-05 | Mount Sinai School Of Medicine Of The City University Of New York | Use of famotidine and related compounds in the treatment of movement disorders |
US5854267A (en) * | 1995-06-02 | 1998-12-29 | Merck & Co., Inc. | Method for preventing heartburn |
US6455518B2 (en) * | 1996-07-30 | 2002-09-24 | Novartis Ag | Pharmaceutical compositions for the treatment of transplant rejection, autoimmune or inflammatory conditions comprising cyclosporin a and 40-O-(2-hydroxyethyl)-rapamycin |
US6552047B2 (en) * | 1998-11-17 | 2003-04-22 | Nitromed, Inc. | H2 receptor antagonist compounds in combination with nitric oxide donors, compositions and methods of use |
US20030178031A1 (en) * | 1999-05-07 | 2003-09-25 | Du Pen, Inc. | Method for cancer pain treatment |
US20040235802A1 (en) * | 2001-10-11 | 2004-11-25 | Alberto Gimona | Combinations comprising cox-2-inhibitors and aspirin |
US20050053655A1 (en) * | 2003-09-05 | 2005-03-10 | Pharmaceutical Industry Technology And Development Center | Rapid disintegrating tablets (RDTs) for pharmaceutical use and method for preparing the same |
Family Cites Families (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6056143B2 (en) * | 1979-08-02 | 1985-12-09 | 山之内製薬株式会社 | Amidine derivatives and their production method |
US4543370A (en) | 1979-11-29 | 1985-09-24 | Colorcon, Inc. | Dry edible film coating composition, method and coating form |
US5037815A (en) * | 1986-03-04 | 1991-08-06 | Bristol-Myers Squibb Co. | Non-steroidal anti-inflammatory compositions protected against gastrointestinal injury with a combination of certain H1 - and H2 -receptor blockers |
HU196775B (en) * | 1986-08-05 | 1989-01-30 | Richter Gedeon Vegyeszet | Process for production of morfologically unique new modifications of famotidin and medical compositions containing such substances |
US5204118A (en) * | 1989-11-02 | 1993-04-20 | Mcneil-Ppc, Inc. | Pharmaceutical compositions and methods for treating the symptoms of overindulgence |
JP2542122B2 (en) * | 1990-04-18 | 1996-10-09 | 旭化成工業株式会社 | Spherical nucleus, spherical granule and method for producing the same |
EP0452862B1 (en) * | 1990-04-18 | 1995-07-19 | Asahi Kasei Kogyo Kabushiki Kaisha | Spherical seed cores, spherical granules and process for production thereof |
DK0584108T3 (en) * | 1991-05-13 | 2000-10-09 | Boots Co Plc | A pharmaceutical composition comprising ibuprofen salt |
ES2130152T3 (en) * | 1991-12-06 | 1999-07-01 | Glaxo Group Ltd | MEDICINES TO TREAT INFLAMMATORY PAIN OR ANALGESIA CONTAINING A NSAID AND RANITIDINE / BISMUTE CITRATE. |
CA2144155A1 (en) * | 1992-09-29 | 1994-04-14 | Robert T. Sims | Ibuprofen-h2 antagonist combinations |
ES2134796T3 (en) * | 1992-12-01 | 1999-10-16 | Spirig Ag Pharmazeutische Prap | PHARMACEUTICAL COMPOSITIONS CONTAINING S (+) - IBUPROFEN. |
ES2082723B1 (en) * | 1994-07-20 | 1996-10-01 | Lilly Sa | PHARMACEUTICAL FORMULATION OF FLUOXETINE IN A DISPERSIBLE FORM. |
DE19509805A1 (en) * | 1995-03-21 | 1996-09-26 | Basf Ag | Transparent, fast-release formulations of nonsteroidal analgesics |
SE9600070D0 (en) * | 1996-01-08 | 1996-01-08 | Astra Ab | New oral pharmaceutical dosage forms |
US5997905A (en) * | 1998-09-04 | 1999-12-07 | Mcneil-Ppc | Preparation of pharmaceutically active particles |
FR2785539B1 (en) * | 1998-11-06 | 2004-04-09 | Prographarm Laboratoires | PARTICLES COATED WITH GRANULATED CRYSTALLINE IBUPROFENE |
US6248363B1 (en) * | 1999-11-23 | 2001-06-19 | Lipocine, Inc. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
US6294192B1 (en) * | 1999-02-26 | 2001-09-25 | Lipocine, Inc. | Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents |
US6660303B2 (en) * | 1999-12-06 | 2003-12-09 | Edward Mendell & Co. | Pharmaceutical superdisintegrant |
ATE474559T1 (en) * | 2001-06-01 | 2010-08-15 | Pozen Inc | PHARMACEUTICAL COMPOSITIONS FOR COORDINATED DELIVERY OF NSAIDS |
AR043444A1 (en) * | 2003-03-05 | 2005-07-27 | Merck Frosst Canada Inc | PROFARMACOS DE DIARIL-2- 5H -FURANONAS THAT RELEASE NITRIC OXIDE AS INHIBITORS OF CYCLLOXYGENASA-2 |
EP1691789B1 (en) * | 2003-11-25 | 2017-12-20 | SmithKline Beecham (Cork) Limited | Carvedilol free base, salts, anhydrous forms or solvate thereof, corresponding pharmaceutical compositions, controlled release formulations, and treatment or delivery methods |
US20050163847A1 (en) * | 2004-01-21 | 2005-07-28 | Andrx Pharmaceuticals, Llc | Pharmaceutical formulations containing a non-steroidal antiinflammatory drug and an antiulcerative drug |
CA2554271A1 (en) * | 2004-02-10 | 2005-08-25 | Santarus, Inc. | Combination of proton pump inhibitor, buffering agent, and nonsteroidal anti-inflammatory agent |
US20060177504A1 (en) * | 2005-02-08 | 2006-08-10 | Renjit Sundharadas | Combination pain medication |
CA2511158A1 (en) * | 2005-06-29 | 2006-12-29 | Medical Futures Inc. | Medicated gumstick for treatment in anti-inflammatory conditions and prophylaxis against nsaid gastropathy |
US20080021078A1 (en) * | 2006-07-18 | 2008-01-24 | Horizon Therapeutics, Inc. | Methods and medicaments for administration of ibuprofen |
US8067451B2 (en) * | 2006-07-18 | 2011-11-29 | Horizon Pharma Usa, Inc. | Methods and medicaments for administration of ibuprofen |
-
2006
- 2006-07-18 US US11/489,705 patent/US20070043097A1/en not_active Abandoned
- 2006-07-18 CA CA2615496A patent/CA2615496C/en not_active Expired - Fee Related
- 2006-07-18 NZ NZ565846A patent/NZ565846A/en not_active IP Right Cessation
- 2006-07-18 CN CN2006800324428A patent/CN101257800B/en not_active Expired - Fee Related
- 2006-07-18 EP EP06800140A patent/EP1919288A4/en not_active Withdrawn
- 2006-07-18 WO PCT/US2006/028078 patent/WO2007012022A2/en active Application Filing
- 2006-07-18 WO PCT/US2006/028075 patent/WO2007012019A2/en active Application Filing
- 2006-07-18 JP JP2008522937A patent/JP2009501801A/en active Pending
- 2006-07-18 US US11/489,275 patent/US20070043096A1/en not_active Abandoned
-
2008
- 2008-01-13 IL IL188732A patent/IL188732A/en not_active IP Right Cessation
-
2013
- 2013-02-15 US US13/769,196 patent/US20140066485A1/en not_active Abandoned
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5496836A (en) * | 1994-05-05 | 1996-03-05 | Mount Sinai School Of Medicine Of The City University Of New York | Use of famotidine and related compounds in the treatment of movement disorders |
US5854267A (en) * | 1995-06-02 | 1998-12-29 | Merck & Co., Inc. | Method for preventing heartburn |
US6455518B2 (en) * | 1996-07-30 | 2002-09-24 | Novartis Ag | Pharmaceutical compositions for the treatment of transplant rejection, autoimmune or inflammatory conditions comprising cyclosporin a and 40-O-(2-hydroxyethyl)-rapamycin |
US6552047B2 (en) * | 1998-11-17 | 2003-04-22 | Nitromed, Inc. | H2 receptor antagonist compounds in combination with nitric oxide donors, compositions and methods of use |
US20030178031A1 (en) * | 1999-05-07 | 2003-09-25 | Du Pen, Inc. | Method for cancer pain treatment |
US20040235802A1 (en) * | 2001-10-11 | 2004-11-25 | Alberto Gimona | Combinations comprising cox-2-inhibitors and aspirin |
US20050053655A1 (en) * | 2003-09-05 | 2005-03-10 | Pharmaceutical Industry Technology And Development Center | Rapid disintegrating tablets (RDTs) for pharmaceutical use and method for preparing the same |
Non-Patent Citations (2)
Title |
---|
COHEN: "Dose Discrepancies Between the Physicians Desk Reference and the Medical Literature, and Their Possible Role in the High Incidence of Dose-Related Adverse Drug Events", ARCHIVE OF INTERNAL MEDICINE, vol. 161, no. 7, 9 April 2001 (2001-04-09), pages 957 - 964, XP008018149 * |
WELAGE: "Overview of pharmacologic agents for acid suppression in critically ill patients", AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, vol. 62, no. 10, SUPPL. 2, 15 May 2005 (2005-05-15), pages S4 - S11, XP008130760 * |
Also Published As
Publication number | Publication date |
---|---|
EP1919288A2 (en) | 2008-05-14 |
IL188732A0 (en) | 2008-08-07 |
JP2009501801A (en) | 2009-01-22 |
WO2007012022A2 (en) | 2007-01-25 |
WO2007012019A2 (en) | 2007-01-25 |
CA2615496C (en) | 2014-11-18 |
CN101257800B (en) | 2012-07-18 |
AU2006269894A1 (en) | 2007-01-25 |
US20070043097A1 (en) | 2007-02-22 |
CA2615496A1 (en) | 2007-01-25 |
EP1919288A4 (en) | 2009-12-16 |
CN101257800A (en) | 2008-09-03 |
WO2007012022A3 (en) | 2007-07-19 |
IL188732A (en) | 2014-07-31 |
US20140066485A1 (en) | 2014-03-06 |
NZ565846A (en) | 2011-12-22 |
US20070043096A1 (en) | 2007-02-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2007012019A3 (en) | Medicaments containing famotidine and ibuprofen and administration of same | |
WO2008011426A3 (en) | Methods and medicaments for administration of ibuprofen | |
WO2008040534A3 (en) | Non-mucoadhesive film dosage forms | |
WO2008085765A3 (en) | Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain | |
WO2008064192A3 (en) | Modified release analgesic suspensions | |
WO2008157103A3 (en) | Modified release solid or semi-solid dosage forms | |
WO2008027350A3 (en) | Acetaminophen pharmaceutical compositions | |
WO2007081949A3 (en) | Small-volume oral transmucosal dosage forms | |
NZ597378A (en) | Treatment of multiple sclerosis with laquinimod | |
WO2008027854A3 (en) | Pharmaceutical compositions comprising hgh for oral delivery | |
FI3782612T3 (en) | Oral formulations of cytidine analogs and methods of use thereof | |
MX2009002196A (en) | Buprenophine-wafer for drug substitution therapy. | |
TW200600117A (en) | Preparation for oral administration | |
WO2006056711A3 (en) | Oral medicament for the modified release of at least one active principle, in multimicrocapsule form | |
CA2570474A1 (en) | A combination composition comprising paracetamol and ibuprofen | |
JP2006504795A5 (en) | ||
WO2006029036A3 (en) | Combination therapy with glatiramer acetate and n-acetylcysteine for the treatment of multiple sclerosis | |
JP2012515184A5 (en) | ||
WO2007018588A8 (en) | Stable pharmaceutical composition comprising linezolid form iv | |
NZ605469A (en) | Nalbuphine-based formulations and uses thereof | |
WO2009022821A3 (en) | Combination preparation comprising inhibitor of hmg-coa reductase and aspirin and method for manufacturing the same | |
NZ587202A (en) | Methods for measuring a patient response upon administration of a drug and compositions thereof | |
WO2008022189A3 (en) | Administration of high potency platinum compound formulations by inhalation | |
WO2008106689A3 (en) | Breakthrough pain management | |
WO2008012796A3 (en) | Pharmaceutical compositions comprising ccl2 and use of same for the treatment of inflammation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 200680032442.8 Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 188732 Country of ref document: IL |
|
ENP | Entry into the national phase |
Ref document number: 2615496 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2008522937 Country of ref document: JP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2006269894 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 565846 Country of ref document: NZ Ref document number: 2006800140 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2006269894 Country of ref document: AU Date of ref document: 20060718 Kind code of ref document: A |